Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 16 min 32 sec ago

EnteroMedics Announces First-of-its-Kind Procedure with vBloc(R) Therapy Used as Adjunctive Rescue Treatment for Failed Gastric Sleeve in Patients with Obesity

Wed, 06/01/2016 - 13:41
ST. PAUL, Minn., June 1, 2016 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced...
EnteroMedics, vBloc , Neurometabolic Therapy

Oncternal Therapeutics Merges with Tokalas to Form Clinical-Stage Biotechnology Company with Promising Oncology Pipeline

Wed, 06/01/2016 - 13:36
Experienced Management Team Appointed to Lead Combined Company to be Oncternal Therapeutics SAN DIEGO, June 1, 2016 -- (Healthcare Sales & Marketing Network) -- Oncternal Therapeutics, Inc. and Tokalas, Inc., today announced that the two companies have...
Biopharmaceuticals, Oncology, Mergers & Acquisitions
Oncternal Therapeutics, Tokalas, Cirmtuzumab, TK216

Elekta’s Leksell Gamma Knife Icon Cleared for Use in Japan and United States

Wed, 06/01/2016 - 13:26
Patients and Clinics to Benefit from Next Generation Stereotactic Radiosurgery System TOKYO and WASHINGTON--(Healthcare Sales & Marketing Network)--Elekta (EKTA-B.ST) announces that Elekta’s Leksell Gamma Knife® Icon™ has been cleared for clinical u...
Devices, Oncology, Neurosurgery, Regulatory
Elekta, Leksell, Gamma Knife Icon, radiosurgery, radiotherapy

Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients

Tue, 05/31/2016 - 14:08
Label Now Includes New Data on Use of TEFLARO in Pediatric Patients 2 Months of Age to Less than 18 Years of Age with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Community-Acquired Bacterial Pneumonia (CABP) TEFLARO is the First Bran...
Biopharmaceuticals, FDA

Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share

Tue, 05/31/2016 - 13:41
Transaction would add VYXEOS™, an investigational product in development as a treatment for Acute Myeloid Leukemia (AML), to Jazz Pharmaceuticals' portfolio U.S. regulatory submission for VYXEOS planned by end of third quarter 2016 Jazz Pharmaceutica...
Biopharmaceuticals, Oncology, Mergers & Acquisitions
Jazz Pharmaceuticals, Celator Pharmaceuticals, VYXEOS

BioVentrix receives FDA IDE Approval for its Pivotal Clinical Trial, ALIVE

Tue, 05/31/2016 - 13:33
SAN RAMON, Calif., May 31, 2016 -- (Healthcare Sales & Marketing Network) -- BioVentrix Inc., an emerging medical device company for less invasive treatment of heart failure (HF), today announced that it has received a U.S. Food and Drug Administration (F...
Devices, Interventional, Cardiology, FDA
BioVentrix, Revivent TC, TransCatheter, Ventricular Enhancement System

Pixium Vision Receives Clinical Trial Approval from UK Regulatory Authority for 150 Electrode IRIS(R)II Bionic Vision System

Tue, 05/31/2016 - 13:27
World renowned Moorfields Eye Hospital joins the clinical trial for IRIS® II, a bionic vision system equipped with a bio-inspired camera and a 150 electrode epi-retinal implant with an explantable design PARIS, May 31, 2016 -- (Healthcare Sales & Ma...
Devices, Ophthalmology, Regulatory
Pixium Vision, IRIS II, bionic vision, epi-retinal implant

FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union

Mon, 05/30/2016 - 14:13
Biogen to manufacture and commercialize FLIXABI, the company’s second anti-TNF biosimilar therapy in the EU ZUG, Switzerland--(Healthcare Sales & Marketing Network)--The European Commission (EC) today granted marketing authorization in the European Unio...
Biopharmaceuticals, Regulatory
Biogen, FLIXABI, biosimilar, Remicade

Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thrombosis and Haemostasis (ISTH) Meeting

Fri, 05/27/2016 - 13:37
Company Plans to Submit NDA and MAA for Betrixaban in Second Half of 2016 Webcast with APEX Study Executive Committee Members Today at 11 a.m. ET MONTPELLIER, France, and SOUTH SAN FRANCISCO, Calif. , May 27, 2016 -- (Healthcare Sales & Marketing Net...
Portola Pharmaceuticals, betrixaban, thrombosis

Aclaris Therapeutics Announces $20.0 Million Private Placement

Fri, 05/27/2016 - 13:28
MALVERN, Pa., May 27, 2016 -- (Healthcare Sales & Marketing Network) -- Aclaris Therapeutics, Inc. (ACRS), a clinical-stage specialty pharmaceutical company, announced today that it has entered into a stock purchase agreement with a group of institutional ...
Biopharmaceuticals, Dermatology, Venture Capital
Aclaris Therapeutics, JAK inhibitor

AbbVie's HUMIRA(R) (adalimumab) Receives CHMP Positive Opinion to Treat Certain Forms of Non-Infectious Uveitis, a Disease that Can Severely Impact Vision

Fri, 05/27/2016 - 13:20
If approved by the European Commission, HUMIRA would be the first biologic treatment option in the European Union for certain patients with non-infectious intermediate, posterior and panuveitis The opinion is based on results from two pivotal Phase 3 st...
Biopharmaceuticals, Ophthalmology, Regulatory
AbbVie, HUMIRA, adalimumab, uveitis

Acumed Launches New State-of-the-Art System for Ankle Fractures

Thu, 05/26/2016 - 20:55
The Acumed Ankle Plating System 3 is composed of seven plate families that span the lateral, medial, and posterior malleoli. PORTLAND, Ore., May 26, 2016 -- (Healthcare Sales & Marketing Network) -- The Acumed Ankle Plating System 3 and Small Fragment ...
Devices, Orthopaedic, Product Launch
Acumed, Ankle Plating System 3, ankle fracture

New Study Highlights Potential Cost Savings When Using Yttrium-90 Glass Microspheres for Treatment of Hepatocellular Carcinoma

Thu, 05/26/2016 - 15:30
TARE (Transarterial Radio-embolization) Using Yttrium-90 Glass Microspheres, Associated With Both Cost Savings and Overall Decreased Use of Hospital Resource WASHINGTON, May 26, 2016 -- (Healthcare Sales & Marketing Network) -- BTG plc (BTG.L), an inte...
Devices, Oncology
BTG, TheraSphere, Yttrium-90, Microspheres, hepatocellular carcinoma

Dynatronics Strengthens Its Sales Management Team

Thu, 05/26/2016 - 13:41
COTTONWOOD HEIGHTS, Utah, May 26, 2016 -- (Healthcare Sales & Marketing Network) -- Dynatronics Corporation (DYNT), a manufacturer and distributor of advanced-technology medical devices and rehabilitation equipment for the physical therapy, sports medicin...
Devices, Orthopaedic, Personnel
Dynatronics, physical therapy, rehabilitation equipment

TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy

Thu, 05/26/2016 - 13:36
ANDOVER, Mass., May 26, 2016 -- (Healthcare Sales & Marketing Network) -- TransMedics, Inc., a medical technology company dedicated to improving quality, assessing viability and increasing the utilization of donor organs for transplantation announces toda...
Devices, Venture Capital
TransMedics, Organ Care System

Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller

Thu, 05/26/2016 - 13:29
LAVAL, Quebec, May 26, 2016 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) ("Valeant") today announced that Sam Eldessouky has been named Senior Vice President and Corporate Controller effect...
Biopharmaceuticals, Personnel
Valeant Pharmaceuticals International

Third Installation of Elekta’s High-Field MR-Guided Linear Accelerator Underway at University Medical Centre Utrecht

Thu, 05/26/2016 - 13:23
Reinforces commitment to research exploring how real-time clinical imaging coupled with precision radiotherapy can improve patient outcomes STOCKHOLM--(Healthcare Sales & Marketing Network)--Elekta (EKTA-B.ST) and Royal Philips (NYSE:PHG, AEX:PHIA) toda...
Devices, Oncology
Elekta, Royal Philips, MR-guided linear accelerator, MR-linac

HeartStitch(R) Announces New Director of Regulatory Affairs and Quality Assurance

Wed, 05/25/2016 - 17:19
Faye Dunn Brings Wide-Ranging Experience to HeartStitch(R) Management and Manufacturing FOUNTAIN VALLEY, CA--(Healthcare Sales & Marketing Network) - Following a detailed search among a field of highly qualified candidates, the HeartStitch® Board of...
Devices, Cardiology, Personnel
HeartStitch, NobleStitch, vascular suture, PFO

Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer

Wed, 05/25/2016 - 17:07
WESTFORD, Mass., May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (CYNO) today announced that Timothy W. Baker has notified the Company that he plans to retire to pursue philanthropic interests. Mr. Baker has served as Cynosure's P...
Devices, Personnel
Cynosure, SculpSure

Ceterix Announces Appointment of Edward Graubart as Vice President, Sales

Wed, 05/25/2016 - 13:56
Seasoned Executive Brings Wealth of Sales, Product Launch Experience MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally i...
Devices, Orthopaedic, Personnel
Ceterix Orthopaedics, NovoStitch Plus, meniscal tear

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong